Stability, BUD, and Reference Use

Stability is a product-specific question

Stability means the preparation stays acceptable in strength, purity, appearance, and safety for the intended time and conditions. A drug may be stable in one concentration, diluent, container, and temperature yet unacceptable under another set of conditions. Stability is about the chemistry of the drug; sterility is about microbial contamination. The assigned beyond-use date must satisfy both.

Stability factors named in the CSPT outline

BUD thinking

A beyond-use date (BUD) is the latest date or time a CSP should be used when stored as directed. It is not the manufacturer's expiration date — an expiration date applies to the unopened commercial product; a BUD applies to your finished compound. BUD assignment weighs drug stability plus the microbial risk introduced by the preparation process and environment.

USP <797> (2023) BUD categories

The revised USP General Chapter <797> bases the default microbial BUD on the environment where the CSP is made, not on the old low/medium/high risk levels. Memorize the Category 1 and Category 2 defaults:

Immediate-use CSPs (emergency/urgent, simple preparation) carry a 4-hour BUD with stricter limits. Whenever documented chemical stability is shorter than the microbial BUD, the shorter stability limit wins. PTCB's outline lists temperature, microbial sterility limits, storage time, complexity of preparation, and location of preparation as BUD factors. Always apply the most conservative applicable evidence and facility policy.

Reference selection

A Safety Data Sheet (SDS) differs from a package insert. The SDS supports worker safety by describing hazards, exposure controls, spill response, storage precautions, and disposal — critical when handling NIOSH-listed hazardous drugs. The package insert tells you how to make and store the drug for the patient; the SDS tells you how to protect yourself.

Worked BUD example

A pharmacy compounds a patient-specific antibiotic syringe in its ISO-classified cleanroom (Category 2) and does not run a sterility test on the batch. The drug's stability reference says the active ingredient retains acceptable potency for 7 days refrigerated. What BUD is assigned?

• USP <797> Category 2, refrigerated, no sterility test allows up to 10 days.
• Documented chemical stability is only 7 days.
• The shorter limit controls, so the assigned BUD is 7 days refrigerated (2-8 C), labeled with the exact date/time and storage condition.

If the same product were made in a segregated compounding area (Category 1), the microbial limit would drop to 24 hours refrigerated regardless of the 7-day chemistry — the environment, not the drug, would be the constraint. This "take the shorter of the two" logic is one of the most heavily tested BUD concepts.

Labeling, documentation, and storage tie-in

Every CSP label must show the BUD with storage conditions, not just a date. "Discard after 06/15/2026 1400, refrigerate" is complete; "good for a few days" is not. The technician also records the lot and expiration of each source component and the master formulation or order reference, so any later stability or recall question is traceable. A BUD with no storage condition and no traceable components is an incomplete CSP — a common distractor on the exam.

Temperature is the lever that most changes a microbial BUD: colder is generally longer, because microbial growth slows. But cold can also harm products — some proteins and emulsions cannot be frozen, and a few drugs precipitate when refrigerated and must stay at controlled room temperature. You cannot blindly refrigerate to extend a BUD; confirm the product tolerates that temperature first. Light-sensitive drugs need amber bags or overwraps, and that protection is part of the storage condition the BUD assumes.

If a CSP sits out of its required condition beyond the allowed excursion, its BUD no longer applies and the product must be reassessed or discarded — another frequently tested scenario.